Heelan R[au] - Search Results

Year	Number of Results
1977	1
1978	2
1979	1
1980	1
1981	3
1982	2
1983	6
1984	3
1985	9
1986	5
1987	7
1988	5
1989	2
1990	5
1991	8
1992	4
1993	11
1994	6
1995	7
1996	4
1997	6
1999	5
2000	5
2001	1
2002	1
2003	3
2004	4
2005	5
2006	4
2007	3
2008	2
2009	1
2010	1
2011	2
2015	1
2024	0

1

A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia.

Feinstein MB, DeSouza SA, Moreira AL, Stover DE, Heelan RT, Iyriboz TA, Taur Y, Travis WD. Feinstein MB, et al. Among authors: heelan rt. J Clin Pathol. 2015 Jun;68(6):441-7. doi: 10.1136/jclinpath-2014-202626. Epub 2015 Mar 5. J Clin Pathol. 2015. PMID: 25742910

2

Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene.

Rizvi NA, Rusch V, Pao W, Chaft JE, Ladanyi M, Miller VA, Krug LM, Azzoli CG, Bains M, Downey R, Flores R, Park B, Singh B, Zakowski M, Heelan RT, Shen R, Kris MG. Rizvi NA, et al. Among authors: heelan rt. Clin Cancer Res. 2011 May 15;17(10):3500-6. doi: 10.1158/1078-0432.CCR-10-2102. Epub 2011 May 10. Clin Cancer Res. 2011. PMID: 21558399 Free PMC article. Clinical Trial.

3

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.

Paik PK, James LP, Riely GJ, Azzoli CG, Miller VA, Ng KK, Sima CS, Heelan RT, Kris MG, Moore E, Rizvi NA. Paik PK, et al. Among authors: heelan rt. Cancer Chemother Pharmacol. 2011 Nov;68(5):1331-7. doi: 10.1007/s00280-011-1621-0. Epub 2011 Apr 3. Cancer Chemother Pharmacol. 2011. PMID: 21461889 Free PMC article. Clinical Trial.

4

Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.

Price KA, Azzoli CG, Krug LM, Pietanza MC, Rizvi NA, Pao W, Kris MG, Riely GJ, Heelan RT, Arcila ME, Miller VA. Price KA, et al. Among authors: heelan rt. J Thorac Oncol. 2010 Oct;5(10):1623-9. doi: 10.1097/JTO.0b013e3181ec1531. J Thorac Oncol. 2010. PMID: 20871262 Free PMC article. Clinical Trial.

5

Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.

Zakowski MF, Hussain S, Pao W, Ladanyi M, Ginsberg MS, Heelan R, Miller VA, Rusch VW, Kris MG. Zakowski MF, et al. Among authors: heelan r. Arch Pathol Lab Med. 2009 Mar;133(3):470-7. doi: 10.5858/133.3.470. Arch Pathol Lab Med. 2009. PMID: 19260752 Free PMC article.

6

Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.

Miller VA, Riely GJ, Zakowski MF, Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, Herbst RS, Heller G, Ladanyi M, Pao W, Johnson DH. Miller VA, et al. Among authors: heelan rt. J Clin Oncol. 2008 Mar 20;26(9):1472-8. doi: 10.1200/JCO.2007.13.0062. J Clin Oncol. 2008. PMID: 18349398 Clinical Trial.

7

Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.

Rizvi NA, Riely GJ, Azzoli CG, Miller VA, Ng KK, Fiore J, Chia G, Brower M, Heelan R, Hawkins MJ, Kris MG. Rizvi NA, et al. Among authors: heelan r. J Clin Oncol. 2008 Feb 1;26(4):639-43. doi: 10.1200/JCO.2007.10.8605. J Clin Oncol. 2008. PMID: 18235124 Clinical Trial.

8

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA. Milton DT, et al. Among authors: heelan rt. Cancer. 2007 Aug 1;110(3):599-605. doi: 10.1002/cncr.22816. Cancer. 2007. PMID: 17577220 Free article. Clinical Trial.

9

Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.

Gandara DR, Aberle D, Lau D, Jett J, Akhurst T, Heelan R, Mulshine J, Berg C, Patz EF Jr. Gandara DR, et al. Among authors: heelan r. J Thorac Oncol. 2006 Nov;1(9 Suppl):S20-6. J Thorac Oncol. 2006. PMID: 17409997 Free article. Review.

10

Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.

Flores RM, Krug LM, Rosenzweig KE, Venkatraman E, Vincent A, Heelan R, Akhurst T, Rusch VW. Flores RM, et al. Among authors: heelan r. J Thorac Oncol. 2006 May;1(4):289-95. J Thorac Oncol. 2006. PMID: 17409872 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year